alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2014397EN.01000401.xml

| 12.11.2014 | EN | Official Journal of the European Union | C 397/4 |
| --- | --- | --- | --- |

12.11.2014

EN

Official Journal of the European Union

C 397/4

---

New national side of euro coins intended for circulation

2014/C 397/05

Image

National side of the new commemorative 2-euro coin intended for circulation and issued by Finland

National side of the new commemorative 2-euro coin intended for circulation and issued by Finland

Euro coins intended for circulation have legal tender status throughout the euro area. For the purpose of informing the public and all parties who handle the coins, the Commission publishes a description of the designs of all new coins (1). In accordance with the Council conclusions of 10 February 2009 (2), euro-area Member States and countries that have concluded a monetary agreement with the European Union providing for the issuing of euro coins are allowed to issue commemorative euro coins intended for circulation, provided that certain conditions are met, particularly that only the 2-euro denomination is used. These coins have the same technical characteristics as other 2-euro coins, but their national face features a commemorative design that is highly symbolic in national or European terms.

1

2

Issuing country
  : Finland

Issuing country

Subject of commemoration
  : The 100th Anniversary of the birth of designer and interior designer Ilmari Tapiovaara.

Subject of commemoration

Description of the design
  : The left inner part of the design shows Ilmari Tapiovaara’s name and years. The right inner part of the design depicts a close-up from the furniture fitting characteristic for Ilmari Tapiovaara. At the right the indication of the issuing country ‘FI’, the mint mark and the year of issuance ‘2014’.

Description of the design

The coin’s outer ring depicts the 12 stars of the European flag.

Number of coins to be issued
  :

Number of coins to be issued

Date of issue
  : October/November 2014

Date of issue

---

(1)  See OJ C 373, 28.12.2001, p. 1 for the national faces of all the coins issued in 2002.

1

(2)  See the conclusions of the Economic and Financial Affairs Council of 10 February 2009 and the Commission Recommendation of 19 December 2008 on common guidelines for the national sides and the issuance of euro coins intended for circulation (OJ L 9, 14.1.2009, p. 52).

2

---
Exhibit 11

<TABLE>
Comtex Scientific Corporation
Earnings Per Share Computation
<CAPTION>

                          
                              Three Months Ended  
                              September 30,
                              1997                1996      
                              ---------           --------- 
<S>                           <C>                 <C>       
                                                            
Net Income                    $  3,667            $ 28,933  
                                                            
Add:
Interest expense savings
assuming repayment of
debt from excess proceeds
of exercise of stock
options under treasury
stock method assuming 20%
of outstanding shares
limitation                       2,074               -   
                              ---------           --------- 
                              
                              $  5,741            $ 28,933  
                              =========           ========= 
Weighted average shares:                                    
                                                            
Shares outstanding            7,854,667           7,854,667 
                                                            
Common stock equivalents      2,139,303             -       
                              ---------           --------- 
                              9,993,970           7,854,667 
                              =========           ========= 

Earnings per share             $ 5,741  = $.00    $ 28,933 = $.00
                              ---------           ---------
                              9,993,970           7,854,667
                          
</TABLE>
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-16-00086-CV

Debra Knox, Steven Dunning, 

Pamela Johnson, and Penny Ortiz, 

Individually and as Representative of 

the Estate of Patty Dunning, 

Deceased

v.

Tahir Rana, M.D., North Texas 

Cancer Center, L.P., and Gainesville 

Cancer Center, LLC

§

§

§

§

From the 235th District Court

of Cooke County (14-00009)

November 17, 2016

Opinion by Justice Walker

JUDGMENT

This court has considered the record on appeal in this case and holds that 

there was no error in the trial court’s judgment. It is ordered that the judgment of 

the trial court is affirmed.

It is further ordered that appellants Debra Knox, Steven Dunning, Pamela 

Johnson, and Penny Ortiz, Individually and as Representative of the Estate of 

Patty Dunning, Deceased, shall pay all of the costs of this appeal, for which let 

execution issue. 

SECOND DISTRICT COURT OF APPEALS 

By __/s/ Sue Walker__________________

 Justice Sue Walker
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350



AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES OXLEY ACT OF 2002



In connection with the Quarterly Report of Unigene Laboratories, Inc. (the Company) on Form 10-Q/A for the period ending June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Warren P. Levy, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and



(2) the information contained in the
Report fairly presents, in all material respects, the financial position and results of operations of the Company.



|                       
|-----------------------
|/s/ Warren P. Levy     
|Warren P. Levy         
|Chief Executive Officer
|December 30, 2004      



A signed original of this written
statement required by Section 906 has been provided to Unigene Laboratories, Inc. and will be retained by Unigene Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
**Exhibit      32.2**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

**Company**
**Form 10-Q**

| (1)   | the                Form 10-Q fully complies with the requirements of section 13(a) or                15(d)                of the Securities Exchange Act of 1934;                and |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | information                contained in the Form 10-Q fairly presents, in all material respects,                the                financial condition and results of operations of the                Company. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                             /s/                David A. Martin                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                             David                A. Martin                            Vice                President and Chief Financial Officer                            (Principal                Financial Officer) |
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A17E0016. D”ANDRE DOUGLAS v. THE STATE.

It is hereby ordered that the emergency motion to vacate sentencing order is

hereby DENIED.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

11/16/2016

November 16, 2016
# C_2014336EN.01000401.xml

| 26.9.2014 | EN | Official Journal of the European Union | C 336/4 |
| --- | --- | --- | --- |

26.9.2014

EN

Official Journal of the European Union

C 336/4

---

Non-opposition to a notified concentration

(Case M.7341 — MVD/Postcon/ADVO)

(Text with EEA relevance)

(2014/C 336/03)

On 19 September 2014, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in the German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32014M7341. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32014M7341. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
KEENAN JAMAAL VARNER,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D16-2765

_____________________________/

Opinion filed November 7, 2016.

An appeal from an order of the Circuit Court for Duval County.

Marianne L. Aho, Judge.

Nancy A. Daniels, Public Defender, and Steven L. Seliger, Assistant Public 

Defender, Tallahassee, for Appellant.

Pamela Jo Bondi, Attorney General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

ROBERTS, C.J., JAY and WINSOR, JJ., CONCUR.
# C_2014389EN.01000101.xml

| 4.11.2014 | EN | Official Journal of the European Union | C 389/1 |
| --- | --- | --- | --- |

4.11.2014

EN

Official Journal of the European Union

C 389/1

---

Interest rate applied by the European Central Bank to its main refinancing operations (1):

1

0,05 % on 1 November 2014

Euro exchange rates (2)

2

3 November 2014

2014/C 389/01

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2493 |
| JPY | Japanese yen | 142,19 |
| DKK | Danish krone | 7,4441 |
| GBP | Pound sterling | 0,78085 |
| SEK | Swedish krona | 9,2300 |
| CHF | Swiss franc | 1,2054 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,4640 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,788 |
| HUF | Hungarian forint | 308,64 |
| LTL | Lithuanian litas | 3,4528 |
| PLN | Polish zloty | 4,2188 |
| RON | Romanian leu | 4,4138 |
| TRY | Turkish lira | 2,7839 |
| AUD | Australian dollar | 1,4347 |
| CAD | Canadian dollar | 1,4100 |
| HKD | Hong Kong dollar | 9,6879 |
| NZD | New Zealand dollar | 1,6131 |
| SGD | Singapore dollar | 1,6107 |
| KRW | South Korean won | 1 345,90 |
| ZAR | South African rand | 13,7860 |
| CNY | Chinese yuan renminbi | 7,6447 |
| HRK | Croatian kuna | 7,6655 |
| IDR | Indonesian rupiah | 15 149,62 |
| MYR | Malaysian ringgit | 4,1452 |
| PHP | Philippine peso | 56,215 |
| RUB | Russian rouble | 54,1135 |
| THB | Thai baht | 40,815 |
| BRL | Brazilian real | 3,1106 |
| MXN | Mexican peso | 16,8643 |
| INR | Indian rupee | 76,7133 |

Currency

Exchange rate

USD

US dollar

1,2493

JPY

Japanese yen

142,19

DKK

Danish krone

7,4441

GBP

Pound sterling

0,78085

SEK

Swedish krona

9,2300

CHF

Swiss franc

1,2054

ISK

Iceland króna

NOK

Norwegian krone

8,4640

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,788

HUF

Hungarian forint

308,64

LTL

Lithuanian litas

3,4528

PLN

Polish zloty

4,2188

RON

Romanian leu

4,4138

TRY

Turkish lira

2,7839

AUD

Australian dollar

1,4347

CAD

Canadian dollar

1,4100

HKD

Hong Kong dollar

9,6879

NZD

New Zealand dollar

1,6131

SGD

Singapore dollar

1,6107

KRW

South Korean won

1 345,90

ZAR

South African rand

13,7860

CNY

Chinese yuan renminbi

7,6447

HRK

Croatian kuna

7,6655

IDR

Indonesian rupiah

15 149,62

MYR

Malaysian ringgit

4,1452

PHP

Philippine peso

56,215

RUB

Russian rouble

54,1135

THB

Thai baht

40,815

BRL

Brazilian real

3,1106

MXN

Mexican peso

16,8643

INR

Indian rupee

76,7133

---

(1)  Rate applied to the most recent operation carried out before the indicated day. In the case of a variable rate tender, the interest rate is the marginal rate.

1

(2)  Source: reference exchange rate published by the ECB.

2

Source

---
Flagstaff, AZ 86002Dear. Ms. Gearon:

Thank you, and all of the Navajo Nation residents, for your letter of November 17, 2011 to EPA

Administrator Lisa Jackson regarding your support of US EPA’s Mercury and Air Toxics Standards (MATS)

rulemaking. As you are no doubt aware by now, EPA finalized the MATS rule on December 16, 2011.

EPA shares your concern about threats to public health from mercury and toxic air pollution. The MATS

rule will reduce emissions from new and existing coal and oil-fired power plants, including Navajo

Generating Station, San Juan Power Plant, Cholla Power Plant, and the Four Corners Power Plant. MATS

will also reduce emissions of heavy metals and acid gases which are known or suspected of causing

cancer and other serious health effects.

This new rule will save thousands of lives and prevent more than 100,000 heart and asthma attacks each

year while providing important health protections to the most vulnerable, such as children and older

adults. Detailed information on this rule is available on our web page at: h:tp://www.epa.gov/mats

or by calling our toll-free EPA Region 9 public information hotline at 1-866-947-8000. Please feel free to

share this letter with all interested parties. If you have additional questions or concerns, fee! free to call

me at 520-498-0118.

Sincerely,

L/L 4t /‘JJ

i-(Colleen McKaughan

Associate Director, Air Division

Cc:

Office of Air and Radiation — Immediate Office

Office of International and Tribal Affairs

Region 9 — Immediate Office

Pnnred on 1?ecvcled Paper
# C_2015133EN.01000101.xml

| 24.4.2015 | EN | Official Journal of the European Union | C 133/1 |
| --- | --- | --- | --- |

24.4.2015

EN

Official Journal of the European Union

C 133/1

---

Withdrawal of notification of a concentration

(Case M.7598 — Dr. Oetker/Coppenrath & Wiese)

(Text with EEA relevance)

(2015/C 133/01)

(Council Regulation (EC) No 139/2004)

On 20 March 2015, the Commission received a notification of a proposed concentration between Dr. August Oetker KG (Dr. Oetker, Germany) and Conditorei Coppenrath & Wiese GmbH & Co KG (Coppenrath & Wiese, Germany). On 15 April 2015, the notifying party/ies informed the Commission that it/they withdrew its/their notification.

---
EXHIBIT 32.1

Certification Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code), I, John W. Elias, Chief Executive Officer of Edge Petroleum Corporation, a Delaware corporation (the "Company"), hereby certify, to my knowledge, that:



|Dated: March 13, 2008 |  | /s/JOHN W. ELIAS
|--------------------- |  | ----------------
|                      |  | Name:           

---



QuickLinks
~ . ,. 

..... 

USCIB: 13.5/41 

2 March 1954 

'f OP SEi0Rm 

MEMORANDUM FOR THE MEMBERS OF USCIB: 

Subject: 

Reference: 

Publication in the Press of Classified Comnrunications 

Intelligence Information. 

USCIB 13.5/33 of 21 January 1954. 

l. The reference was considered by the Executive Committe~ at 

its Eleventh Meeting on 26 February 1954. 

2. Except for paragraph 6 ther.eof, USCIBEC recommends that the 

reference be accepted. 

3. With regard to paragraph 6 of the reference, USCIBEC are of 

the opinion that an a priori conclusion is included in the recommendations. 

4. USCIBEC therefore recommends that instead of USCIB appointing an Ad Hoc Committee to "study ways and means of consolidating 

the many COMINT publications now in circulation and of further 

limiting their distribution", the USCIB Security Committee should be 

directed to study the matter in order to define the problem more 

specifically. To that end the Executive Committee has agreed to the 

following course of action: 

a. That each USCIB member other than the Director, NSA be 

requested to furnish to the USCIB Security Committee a statement of 

the nature and extent of all external COMINT distribution made by 

his department or agency in the Washington area. 

b. That the Director, NSA be requested to furnish to the 

USCIB Security Committee a statement of the nature and extent of all 

COMINT distribution made by his National Center in Washington to 

other member departments and agencies of USCIB. 

c. That the USCIB Security Committee be directed to study 

the data acquired in this fashion and submit to the Executive 

Committee a report of the situation in the Washington area together 

with such reconunendations aa it may deem appropriate in the premises. 

USCIB: 13.5/41 

31 

Declassified and approved for release by NSA on 01-23-2015 pursuantto E .0. 1352a 

TO:P SECRET' 
USCIB: 13.5/41 

'f OP SE6Rm" 

Subject: 

2 March 1954 

Publication in the Press of Classified Communications 

Intelligence Information. 

5. The Executive Conunittee expressed its intention of considering whether and to what extent, if any, the scope of this investigation should be expanded further upon receipt of the above-mentioned 

report of the Security Committee. 

6. In accordance with paragraph 11 of USCIB Directive Number l, 

absence of objection of a:ny- member to the above by 1700, Friday, 

12 March 1954, will be considered to constitute approval and the 

Executive Secretary will initiate action as appropriate. 

7. THIS DOCUMENT CONTAINS COMMUNICATIONS INTELLIGENCE INFORMATION 

AND SHALL BE HANDLED ONLY IN CHANNELS EXPRESSLY PROVIDED FOR COMINT. 

USCIB: 13.5/41 - 2 -

TO:P SECRET
CERTIFICATION OF CEO PURSUANT TO THE SARBANES-OXLEY ACT

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002





I, Duane Poliquin, Chief Executive Officer of Almaden Minerals Ltd. (the Company) do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.

This Annual Report on Form 20-F of the Company for the period ended December 31, 2006, as filed with

the Securities and Exchange Commission (the report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.

The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: January 24, 2008





Signed:  /s/Duane Poliquin
# EUR-Lex - - EN

Important legal notice

*|*

#

**Prior notification of a concentration (Case COMP/M.7179 — Silver Lake/WME/IMG) — Candidate case for simplified procedure Text with EEA relevance **

*
Official Journal C 089 , 28/03/2014 P. 0056 - 0056 *

Prior notification of a concentration

(Case COMP/M.7179 — Silver Lake/WME/IMG)

Candidate case for simplified procedure

(Text with EEA relevance)

2014/C 89/08

1. On 20 March 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] by which Silver Lake Group, LLC ("Silver Lake", USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the WME Entertainment Parent, LLC ("WME", USA) and of IMG Worldwide Holdings, Inc. ("IMG", USA).

2. The business activities of the undertakings concerned are:

- Silver Lake is a global leader in technology investing, with over USD 20 billion in combined assets under management,

- WME is a talent agency providing representation and advice to clients in sectors including film, television, music, literature, theatre and public speaking,

- IMG is a sports, entertainment and media company that provides services including sports consulting, multimedia rights management, events management and talent representation to companies and individuals in the sports and entertainment sectors.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2], it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.7179 — Silver Lake/WME/IMG, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

[1] OJ L 24, 29.1.2004, p. 1 (the "Merger Regulation").

[2] OJ C 366, 14.12.2013, p. 5.

--------------------------------------------------